Fortress Biotech, Inc.
FBIO
$3.85
$0.25897.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 56.90M | 56.78M | 56.68M | 62.50M | 63.36M |
| Total Other Revenue | 2.40M | 1.00M | 1.00M | 19.00M | 19.26M |
| Total Revenue | 59.30M | 57.78M | 57.68M | 81.50M | 82.62M |
| Cost of Revenue | 48.70M | 54.03M | 76.15M | 80.29M | 92.34M |
| Gross Profit | 10.60M | 3.75M | -18.47M | 1.21M | -9.72M |
| SG&A Expenses | 109.59M | 91.65M | 83.93M | 77.08M | 76.82M |
| Depreciation & Amortization | 5.55M | 5.30M | 5.05M | 5.40M | 5.40M |
| Other Operating Expenses | -4.55M | -4.55M | -4.55M | -- | -- |
| Total Operating Expenses | 159.29M | 146.44M | 160.58M | 162.77M | 174.56M |
| Operating Income | -99.99M | -88.65M | -102.90M | -81.27M | -91.93M |
| Income Before Tax | -88.95M | -106.12M | -120.45M | -123.08M | -107.04M |
| Income Tax Expenses | 405.00K | 405.00K | 405.00K | 448.00K | 520.00K |
| Earnings from Continuing Operations | -89.35 | -106.52 | -120.86 | -123.53 | -107.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 74.62M | 65.36M | 74.86M | 75.01M | 66.87M |
| Net Income | -14.73M | -41.16M | -46.00M | -48.51M | -40.69M |
| EBIT | -99.99M | -88.65M | -102.90M | -81.27M | -91.93M |
| EBITDA | -95.56M | -84.19M | -98.44M | -76.74M | -87.17M |
| EPS Basic | -1.12 | -2.34 | -2.90 | -3.58 | -3.76 |
| Normalized Basic EPS | 0.17 | 0.15 | 0.15 | 1.27 | -0.38 |
| EPS Diluted | -1.17 | -2.35 | -2.91 | -3.58 | -3.76 |
| Normalized Diluted EPS | 0.16 | 0.15 | 0.15 | 1.27 | -0.38 |
| Average Basic Shares Outstanding | 99.04M | 90.48M | 81.18M | 65.92M | 53.72M |
| Average Diluted Shares Outstanding | 101.98M | 90.48M | 81.18M | 65.92M | 53.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -4.88% | -8.73% | -12.42% | -19.74% |